Long-term growth outcomes in children treated for ch

Maureen M. Jonas, Kathleen B. Schwarz, Regino Gonzalez-Peralta, Steven Lobritto, Jean P. Molleston, Karen F. Murray, Philip Rosenthal, Jessica Wen, Cynthia Wat, Vedran Pavlovic, Charles Warne

Research output: Contribution to journalArticlepeer-review

7 Scopus citations


Effects on linear growth were noted in children treated with peginterferon ± ribavirin in the Pediatric Study of Hepatitis C trial. Growth was further examined in a subset of patients followed for up to 6 years post-treatment. No long-term effects on height-for-age z scores were observed that could be attributed to hepatitis C virus treatment.

Original languageEnglish (US)
Pages (from-to)1252-1254
Number of pages3
JournalJournal of Pediatrics
Issue number6
StatePublished - Dec 1 2014


  • HAZ Height-for-age z score LTFU Long-term follow-up PEG-IFN Peginterferon RBV Ribavirin

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health


Dive into the research topics of 'Long-term growth outcomes in children treated for ch'. Together they form a unique fingerprint.

Cite this